Core Insights - Shenzhen Core Medical Technology Co., Ltd. has disclosed its first round of inquiry response for its IPO on the Sci-Tech Innovation Board [1] - The company focuses on providing comprehensive, innovative, and high-quality artificial heart products, addressing significant clinical needs in acute and chronic heart failure [1] - Core Medical emphasizes original innovation and key core technology breakthroughs to continuously promote product iteration and upgrades in the artificial heart field [1] Inquiry Highlights - The first round of inquiries raised questions regarding the clinical value and competitiveness of implantable and interventional artificial hearts [1] - The inquiries also addressed the commercialization progress and market potential of the company's products [1]
核心医疗科创板IPO披露首轮审核问询函回复
Bei Jing Shang Bao·2026-02-02 12:23